Retest positive for SARS‐CoV‐2 RNA of “recovered” patients with COVID‐19: Persistence, sampling issues, or re‐infection?
- 3 June 2020
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (11), 2263-2265
- https://doi.org/10.1002/jmv.26114
Abstract
“Re‐test Positive” for SARS‐CoV‐2 from “recovered” COVID‐19 has been reported and raised several important questions for this novel coronavirus and COVID‐19 disease. In this commentary, we discussed several questions: 1. Can SARS‐CoV‐2 re‐infect the individuals who recovered from COVID‐19? This question is also associated with other questions: whether or not SARS‐CoV‐2 infection induces protective reaction or neutralized antibody? Will SARS‐CoV‐2 vaccines work? 2. Why could some recovered COVID‐19 patients be re‐tested positive for SARS‐CoV‐2 RNA? 3. Are some recovered COVID‐19 patients with re‐testing positive for SARS‐CoV‐2 RNA infectious? 4. How should the COVID‐19 patients with re‐test positive for SARS‐CoV‐2 be managed?This publication has 17 references indexed in Scilit:
- Positive RT-PCR Test Results in Patients Recovered From COVID-19JAMA, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19Nature Medicine, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19Travel Medicine and Infectious Disease, 2020
- Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case reportInternational Journal of Infectious Diseases, 2020
- Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic ToolsVirologica Sinica, 2020
- Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patientsChinese Medical Journal, 2020
- Combination of RT‐qPCR testing and clinical features for diagnosis of COVID‐19 facilitates management of SARS‐CoV‐2 outbreakJournal of Medical Virology, 2020
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibodyEmerging Microbes & Infections, 2020